Journal of Labelled Compounds and Radiopharmaceuticals
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 1.3 | Q4 | 15.3% | 0.293 | Q3 | 42.7% |
| 2024 | 0.9 | Q4 | 9.0% | 0.271 | Q3 | 42.1% |
| 2023 | 0.9 | Q4 | 16.0% | 0.326 | Q3 | 51.4% |
| 2022 | 1.8 | Q3 | 18.2% | 0.440 | Q2 | 62.3% |
| 2021 | 1.9 | Q4 | 38.1% | 0.468 | Q2 | 65.1% |
| 2020 | — | — | 0.432 | Q3 | 61.8% | |
| 2019 | — | — | 0.468 | Q2 | 65.5% | |
| 2018 | — | — | 0.359 | Q3 | 55.6% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1099-1344
ISSN
0362-4803
country
GBcoverage
1976-2026